251 related articles for article (PubMed ID: 11867746)
21. NAD(P)H-quinone oxidoreductase 1 silencing aggravates hormone-induced prostatic hyperplasia in mice.
Kim HT; Kim YJ; Park SR; Ryu SY; Jung JY
Andrologia; 2018 Apr; 50(3):. PubMed ID: 29110315
[TBL] [Abstract][Full Text] [Related]
22. A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73.
Asher G; Tsvetkov P; Kahana C; Shaul Y
Genes Dev; 2005 Feb; 19(3):316-21. PubMed ID: 15687255
[TBL] [Abstract][Full Text] [Related]
23. NQO1 Stabilizes p53 in Response to Oncogene-Induced Senescence.
Liu K; Jin B; Wu C; Yang J; Zhan X; Wang L; Shen X; Chen J; Chen H; Mao Z
Int J Biol Sci; 2015; 11(7):762-71. PubMed ID: 26078718
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological inhibitors of NAD(P)H quinone oxidoreductase, NQO1: structure/activity relationships and functional activity in tumour cells.
Nolan KA; Scott KA; Barnes J; Doncaster J; Whitehead RC; Stratford IJ
Biochem Pharmacol; 2010 Oct; 80(7):977-81. PubMed ID: 20599803
[TBL] [Abstract][Full Text] [Related]
25. Increased mdm-2 expression in a p53-independent manner blocks UV-induced cell cycle arrest and apoptosis in human osteosarcoma cells.
Dong YB; Yang HL; Elliott MJ; McMasters KM
Tumour Biol; 2003; 24(3):130-9. PubMed ID: 14610316
[TBL] [Abstract][Full Text] [Related]
26. Phosphorylation and hsp90 binding mediate heat shock stabilization of p53.
Wang C; Chen J
J Biol Chem; 2003 Jan; 278(3):2066-71. PubMed ID: 12427754
[TBL] [Abstract][Full Text] [Related]
27. Quinone reductases multitasking in the metabolic world.
Ross D
Drug Metab Rev; 2004 Oct; 36(3-4):639-54. PubMed ID: 15554240
[TBL] [Abstract][Full Text] [Related]
28. Negative Cooperativity in NAD(P)H Quinone Oxidoreductase 1 (NQO1).
Megarity CF; Abdel-Aal Bettley H; Caraher MC; Scott KA; Whitehead RC; Jowitt TA; Gutierrez A; Bryce RA; Nolan KA; Stratford IJ; Timson DJ
Chembiochem; 2019 Nov; 20(22):2841-2849. PubMed ID: 31165578
[TBL] [Abstract][Full Text] [Related]
29. Involvement of the electrophile responsive element and p53 in the activation of hepatic stellate cells as a response to electrophile menadione.
Vasiliou V; Qamar L; Pappa A; Sophos NA; Petersen DR
Arch Biochem Biophys; 2003 May; 413(2):164-71. PubMed ID: 12729613
[TBL] [Abstract][Full Text] [Related]
30. NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism.
Jamieson D; Wilson K; Pridgeon S; Margetts JP; Edmondson RJ; Leung HY; Knox R; Boddy AV
Clin Cancer Res; 2007 Mar; 13(5):1584-90. PubMed ID: 17332305
[TBL] [Abstract][Full Text] [Related]
31. Regulation of p53 stability by Mdm2.
Kubbutat MH; Jones SN; Vousden KH
Nature; 1997 May; 387(6630):299-303. PubMed ID: 9153396
[TBL] [Abstract][Full Text] [Related]
32. Modulation of p53 degradation via MDM2-mediated ubiquitylation and the ubiquitin-proteasome system during reperfusion after stroke: role of oxidative stress.
Saito A; Hayashi T; Okuno S; Nishi T; Chan PH
J Cereb Blood Flow Metab; 2005 Feb; 25(2):267-80. PubMed ID: 15678128
[TBL] [Abstract][Full Text] [Related]
33. DIMP53-1: a novel small-molecule dual inhibitor of p53-MDM2/X interactions with multifunctional p53-dependent anticancer properties.
Soares J; Espadinha M; Raimundo L; Ramos H; Gomes AS; Gomes S; Loureiro JB; Inga A; Reis F; Gomes C; Santos MMM; Saraiva L
Mol Oncol; 2017 Jun; 11(6):612-627. PubMed ID: 28296148
[TBL] [Abstract][Full Text] [Related]
34. Induction of murine NAD(P)H:quinone oxidoreductase by 2,3,7,8-tetrachlorodibenzo-p-dioxin requires the CNC (cap 'n' collar) basic leucine zipper transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2): cross-interaction between AhR (aryl hydrocarbon receptor) and Nrf2 signal transduction.
Ma Q; Kinneer K; Bi Y; Chan JY; Kan YW
Biochem J; 2004 Jan; 377(Pt 1):205-13. PubMed ID: 14510636
[TBL] [Abstract][Full Text] [Related]
35. NAD(P)H: Quinone oxidoreductase 1 overexpression in hepatocellular carcinoma potentiates apoptosis evasion through regulating stabilization of X-linked inhibitor of apoptosis protein.
Li WY; Zhou HZ; Chen Y; Cai XF; Tang H; Ren JH; Wai Wong VK; Kwan Law BY; Chen Y; Cheng ST; Yu HB; Cai HY; Chen WX; Tang N; Zhang WL; Tao NN; Yang QX; Ren F; He L; Jiang H; Huang AL; Chen J
Cancer Lett; 2019 Jun; 451():156-167. PubMed ID: 30867140
[TBL] [Abstract][Full Text] [Related]
36. 20S proteasomal degradation of ornithine decarboxylase is regulated by NQO1.
Asher G; Bercovich Z; Tsvetkov P; Shaul Y; Kahana C
Mol Cell; 2005 Mar; 17(5):645-55. PubMed ID: 15749015
[TBL] [Abstract][Full Text] [Related]
37. NAD(P)H:quinone oxidoreductase 1 (NQO1) localizes to the mitotic spindle in human cells.
Siegel D; Kepa JK; Ross D
PLoS One; 2012; 7(9):e44861. PubMed ID: 22984577
[TBL] [Abstract][Full Text] [Related]
38. NQO1: A target for the treatment of cancer and neurological diseases, and a model to understand loss of function disease mechanisms.
Beaver SK; Mesa-Torres N; Pey AL; Timson DJ
Biochim Biophys Acta Proteins Proteom; 2019; 1867(7-8):663-676. PubMed ID: 31091472
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of the p53-MDM2 interaction by adenovirus delivery of ribosomal protein L23 stabilizes p53 and induces cell cycle arrest and apoptosis in gastric cancer.
Zhang Y; Shi Y; Li X; Du W; Luo G; Gou Y; Wang X; Guo X; Liu J; Ding J; Wu K; Fan D
J Gene Med; 2010 Feb; 12(2):147-56. PubMed ID: 20020415
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of Mdm2 and MdmX fusion proteins alters p53 mediated transactivation, ubiquitination, and degradation.
Ghosh M; Huang K; Berberich SJ
Biochemistry; 2003 Mar; 42(8):2291-9. PubMed ID: 12600196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
